Cathie Wood acquired 6.79 Million Twist Bioscience shares worth $166 Million. That's 1.11% of their equity portfolio (24th largest holding). The investor owns 12.11% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares ten more times and sold shares on five occasions. The investor's estimated purchase price is $445 Million, resulting in a loss of 63%.